Metabolic status of children with growth hormone insensitivity syndrome and responses to treatment with IGF-I

Hormone Research

Volumn 50, Issue 2, 1998, Pages 61-70

  Brain, C E ^a   Hubbard, M ^a   Preece, M A ^a   Savage, M O ^b   Aynsley Green, A ^a,c  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glucose homeostasis; Growth hormone insensitivity syndrome; Growth hormone receptor defect; Hypoglycaemia; Insulin like growth factor I

Indexed keywords

FATTY ACID; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; INSULIN; KETONE; SOMATOMEDIN C;

ARTICLE; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GROWTH RATE; HORMONE RESISTANCE; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; MALE; METABOLISM; METABOLITE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

BLOOD GLUCOSE; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; ENDOCRINE SYSTEM DISEASES; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCEROL; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KETONE BODIES; MALE; RECOMBINANT PROTEINS; SYNDROME;

EID: 0031688127     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023236     Document Type: Article

References (29)

1. Savage MO, Blum WF, Ranke MB, Postal-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA, Rosenfeld RG: Clinical features and endocrine status of patients with GH insensitivity (Laron syndrome). J Clin Endocrinol Metab 1993;77:1465-1471.
2. Rosenfeld RG, Rosenbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev 1994; 15:369-390.
3. Amselem S, Sorbier M-L, Dastot F, Duqeusnoy P, Duriez B, Goossens M: Molecular basis of inherited growth hormone resistance in childhood. Baillières Clin Endocrinol Metab 1996: 10:353-369.
4. Woods KA, Savage MO: Laron syndrome: Typical and atypical forms. Baillières Clin Endocrinol Metab 1996;10:371-387.
5. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO, Wilton P: Improvement of diagnostic criteria in growth hormone insensitivity syndrome: Solutions and pitfalls. Acta Paediatr Suppl 1994;83(suppl 399): 117-124.
6. Nissley SP, Rechler RR: in Li CH (ed): Hormonal Peptides: Growth Factors. New York, Academic Press, 1984, vol XII, pp 127-203.
7. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B: Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 1992;339:1258-1261.
8. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF, Wilton P: Insulin-like growth factor improves height in growth hormone insensitivity: Two years' results. Horm Res 1995;44:253-264.
9. Backeljauw PF, Underwood LE for The GHIS Collaborative Group: Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome: A clinical research center study. J Clin Endocrinol Metab 1996;81:3312-3317.
10. Guler HP, Zapf Y, Froesch ER: Short term effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Mcd 1987;317:137-140.
11. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf H, Froesch ER: Insulin-like growth factor-I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993; 92:2249-2256.
12. Zenobi P, Graf S, Ursprung H, Froesch ER: Effects of insulin-like growth factor-I on glucose tolerance, insulin levels and insulin secretion. J Clin Invest 1992;89:1908-1913.
13. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER: Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycacmia in patients with extreme insulin resistance. Diabetologia 1991;34: 675-679.
14. Walker J, van Wyk JJ, Underwood LE: Stimulation of statural growth by recombinant insulin-like growth factor I in a child with GH insensitivity syndrome (Laron type). J Pediatr 1992;121:641-646.
15. Wilton P: Treatment with recombinant insulin-like growth factor I in children with GH receptor deficiency (Laron syndrome). Acta Pediatr 1992:81(suppl 383):137-141.
16. Laron Z, Parks JS (eds): Lessons from Laron Syndrome (LS), 1966-1992: A model of GH and IGF-1 Action and Interaction. Pediatr Adolesc Endocrinol. Basel, Karger, 1993, vol 24.
17. Harrison J, Hodson AW, Skillen AW, Stappenbeck R, Aqius L, Alberti KGMM: Blood glucose, lactate, pyruvate, glycerol, 3-hydroxybutyrate and acctoacetate measurements in man using a centrifugal analyser with a fluorimetric attachment. J Clin Chem Clin Biochem 1988; 26:141-146.
18. Bang P, Eriksson U, Sara V, Wirall I-L, Hall K: Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extractions by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 1991;124:620-629.
19. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990;70:1292-1298.
20. Tar A, Hocquette JF, Souberbielle JC, Clot JP, Brauner R, Postel-Vinay MC: Evaluation of the growth hormone-binding proteins in human plasma using HPLC-gel filtration. J Clin Endocrinol Metab 1990;71:1202-1207.
21. Wolfsdorf JI, Sadeghi-Nejada B: Hypoketonaemia and age related fasting hypoglycaemia in growth hormone deficiency. Metabolism 1983; 32:457-462.
22. Aynsley-Green A: Glucose, the brain and the paediatric endocrinologist. Horm Res 1996;46: 8-25.
23. Han VKM: Is the central nervous system a target for growth hormone and insulin-like growth factors? Acta Paediatr 1995;84(suppl 411): 3-8.
24. Gerich JE: Control of glycaemia. Baillières Clin Endocrinol Metab 1993;7:551-586.
25. Leberman SA, Buker J, Chen SA: Recombinant human insulin-like growth factor I (rhIGF-I) on total and free IGF-I concentrations, IGF binding proteins, and glycaemic response in humans. J Clin Endocrinol Metab 1992;75:30-36.
26. Grahnen A, Kastrup K, Heinrich U, Gourmelen M, Preece MA, Vaccarrello MA, Guevara-Aquieta J, Rosenfeld RG, Sietnieks A: Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with GH receptor deficiency. Acta Paediatr 1993;82(suppl 391): 9-13.
27. Cotterill AM, Camacho-Hubner C, Holly JM, Savage MO: The effect of recombinant human insulin-like growth factor I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome). Clin Endocrinol (Oxf) 1993;39:119-122.
28. Cotterill AM, Holly JMP, Taylor AM, Davies SC, Coulson VJ, Preece MA, Wass JAH, Savage MO: The insulin-like growth factor (IGF-I) binding proteins and IGF bio-activity in Laron-type dwarfism. J Clin Endocrinol Metab 1992;74:56-63.
29. Fielder PJ, Guevara-Aguirre J, Rosenbloom AL, Carlsson T, Hintz RL, Rosenfeld RG: Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients. J Clin Endocrinol Metab 1992;74:743-750.